In the initial complaint on April 10, 2015, investors accused Walgreens of concealing the impact of higher drug costs on its pharmacy business before the company’s stock price fell.
The pharmaceutical company denied all accusations of wrongdoing and said the decision to settle is “solely to eliminate the uncertainty, burden and expense of further protracted litigation.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
